Myalgic Encephalomyelitis Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Myalgic Encephalomyelitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Patient-Centered Assessment of Symptoms and Outcomes

Myalgic Encephalomyelitis/Chronic Fatigue SyndromeCancerFatigue+5 more
National Center for Complementary and Integrative Health (NCCIH)692 enrolled1 locationNCT03952624
Recruiting

Chronic Infections and Inflammation in ME/CFS: An Observational Study

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
University of California, San Francisco200 enrolled1 locationNCT07227441
Recruiting
Phase 2

Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Myalgic EncephalomyelitisChronic Fatigue Syndrome
Weill Medical College of Cornell University95 enrolled1 locationNCT04542161
Recruiting
Not Applicable

A 3-day Course for CFS/ME

Myalgic EncephalomyelitisChronic Fatigue Syndrome
Norwegian University of Science and Technology100 enrolled1 locationNCT05236465
Recruiting
Not Applicable

RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
University of Alberta200 enrolled3 locationsNCT06933173
Recruiting
Phase 2Phase 3

TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Deakin University126 enrolled1 locationACTRN12625000095460
Recruiting

FUNCAP-27 (Functional Capacity), A Repeat Measure Study (FARMS), A survey to establish the utility of the FUNCAP-27 for serial measurements in Myalgic Encephalomyelitis, Chronic Fatigue Syndrome (ME/CFS) and Long Covid

ME/CFS (Myalgic Encephalomyelitis / Chronic Fatigue Syndrome)
The University of Melbourne1,000 enrolled1 locationACTRN12624001479594
Recruiting

Munich ME/CFS Cohort Study

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
Technical University of Munich200 enrolled1 locationNCT06005246